Researchers in Sweden have investigated how red blood cells change in type 2 diabetes and how this affects the risk of cardiovascular complications. The underlying causes of cardiovascular complications in people with diabetes are partly known but research is uncovering new findings each year. The latest study suggests that in type 2 diabetes red blood cells suffer damage which causes them to release harmful substances.
In a more upbeat discovery, the Karolinska Institutet research team also identified a treatment that inhibited abnormal blood cell function. They hypothesise that the treatment could be developed to potentially prevent harmful cardiovascular effects in humans with type 2 diabetes.
The researchers looked at two studies focusing on red blood cells in people and mice with type 2 diabetes, and explored whether they contributed to poor cardiovascular outcomes.